The Challenge

The Brazilian government is among the world’s largest purchasers of pharmaceutical products, but regulatory processes can also create significant hurdles. A global pharmaceutical firm came to ASG having entered a public-private-partnership (PPP) intended to bring an important life-sustaining product and technology to Brazil. However, implementation was being held up amid legal uncertainty surrounding the agreement and efforts by a local incumbent competitor to impede progress of the PPP.

The ASG Approach

Understanding the high value that our client’s products offered to Brazil, our approach was to raise and enhance the company’s profile, emphasizing areas of mutual benefit. We sought to build trust with stakeholders, overcoming the general skepticism of some towards public-private partnerships with multinational drug makers. Our team worked with the client to create and implement an outreach plan, strengthen relations with its local public sector partner, and successfully navigate the regulatory process. We developed an ongoing dialogue with critical stakeholders including the Ministry of Health, legislators, and health organizations, building public support and securing a positive outcome.

The Result

Our client successfully implemented its partnership, opening the market to its flagship product and providing thousands of Brazilian patients with the most advanced treatment option. The company now operates from a solid foundation for continued growth in Brazil.